Literature DB >> 6894884

Graves' hyperthyroidism and ophthalmopathy following treatment of spontaneous hypothyroidism with levothyroxine.

P A Easton, J R Wall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894884      PMCID: PMC1862576     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  25 in total

1.  A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease.

Authors:  J M McKenzie; M Zakarija
Journal:  J Clin Endocrinol Metab       Date:  1976-04       Impact factor: 5.958

2.  Graves thyrotoxicosis following primary thyroid failure.

Authors:  W J Bremner; R J Griep
Journal:  JAMA       Date:  1976-03-29       Impact factor: 56.272

3.  Thyroid-stimulating immunoglobulins in Graves' disease.

Authors:  B R Smith; R Hall
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

4.  Late thyrotoxicosis complicating autoimmune thyroiditis.

Authors:  I Gavras; J A Thomson
Journal:  Acta Endocrinol (Copenh)       Date:  1972-01

5.  Myxoedema preceding hyperthyroidism.

Authors:  K W James
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

6.  Macrophage migration from an agarose droplet: a micromethod for assay of delayed hypersensitivity in the mouse.

Authors:  J T Harrington
Journal:  Cell Immunol       Date:  1974-06       Impact factor: 4.868

7.  Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.

Authors:  J S Flier; C R Kahn; J Roth; R S Bar
Journal:  Science       Date:  1975-10-03       Impact factor: 47.728

8.  Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test.

Authors:  R E Munro; L Lamki; V V Row; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

9.  Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.

Authors:  E D Mukhtar; B R Smith; G A Pyle; R Hall; P Vice
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

10.  Thyroid-stimulating antibodies in patients with autoimmune disorders.

Authors:  C R Strakosch; D Joyner; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

View more
  3 in total

1.  Long-term follow-up of ophthalmic Graves' disease.

Authors:  P J Agapitos; I R Hart
Journal:  CMAJ       Date:  1987-02-15       Impact factor: 8.262

2.  Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test.

Authors:  P G Walfish; I S Gottesman; J L Baxter
Journal:  Can Med Assoc J       Date:  1982-08-15       Impact factor: 8.262

3.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.